Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
64.1 USD | +1.06% | +0.25% | -20.87% |
Jun. 04 | Sector Update: Health Care Stocks Rise Late Afternoon | MT |
Jun. 04 | Sector Update: Health Care Stocks Rise Tuesday Afternoon | MT |
Chart calendar Gilead Sciences, Inc.
Upcoming events on Gilead Sciences, Inc.
Past events on Gilead Sciences, Inc.
2024-06-03 02:30 pm | American Society of Clinical Oncology Meeting - Abstract No: #TPS8121 |
2024-06-03 02:30 pm | American Society of Clinical Oncology Meeting - Abstract No: #8592 |
2024-06-03 10:00 am | American Society of Clinical Oncology Meeting - Abstract No: #6531 |
2024-06-03 09:00 am | American Society of Clinical Oncology Meeting - Abstract No: #2006 |
2024-06-02 10:00 am | American Society of Clinical Oncology Meeting - Abstract No: #TPS4618 |
2024-06-02 10:00 am | American Society of Clinical Oncology Meeting - Abstract No: #TPS6130 |
2024-06-02 10:00 am | American Society of Clinical Oncology Meeting - Abstract No: #TPS4627 |
2024-06-02 10:00 am | American Society of Clinical Oncology Meeting - Abstract No: #TPS1140 |
2024-06-02 10:00 am | American Society of Clinical Oncology Meeting - Abstract No: #1102 |
2024-06-02 10:00 am | American Society of Clinical Oncology Meeting - Abstract No: #1075 |
2024-06-02 10:00 am | American Society of Clinical Oncology Meeting - Abstract No: #1101 |
2024-06-02 09:00 am | American Society of Clinical Oncology Meeting - Abstract No: #3508 |
2024-06-01 04:00 pm | American Society of Clinical Oncology Meeting - Abstract No: #LBA1004 |
2024-06-01 02:30 pm | American Society of Clinical Oncology Meeting - Abstract No: #TPS4195 |
2024-06-01 01:30 pm | American Society of Clinical Oncology Meeting - Abstract No: #433248 |
2024-06-01 10:00 am | American Society of Clinical Oncology Meeting - Abstract No: #3029 |
2024-05-31 03:45 pm | American Society of Clinical Oncology Meeting - Abstract No: #LBA8500 |
2024-05-23 05:00 pm | American Society of Clinical Oncology Meeting - Abstract No: #e16500 |
2024-05-15 10:30 am | RBC Capital Markets Global Healthcare Conference |
2024-05-14 02:20 pm | BofA Securities Health Care Conference |
Past dividends on Gilead Sciences, Inc.
2024-03-13 | Quarterly 0.77 USD |
2023-12-13 | Quarterly 0.75 USD |
2023-09-13 | Quarterly 0.75 USD |
2023-06-13 | Quarterly 0.75 USD |
2023-03-13 | Quarterly 0.75 USD |
2022-12-13 | Quarterly 0.73 USD |
2022-09-13 | Quarterly 0.73 USD |
2022-06-13 | Quarterly 0.73 USD |
2022-03-13 | Quarterly 0.73 USD |
2021-12-13 | Quarterly 0.71 USD |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 22 449 22 305 0.65% | 24 689 24 482 0.84% | 27 305 26 657 2.43% | 27 281 26 518 2.88% | 27 116 27 083 0.12% | 27 579 |
EBITDA Million USD | Released Forecast Spread | 12 468 13 029 -4.3% | 13 184 13 142 0.32% | 14 598 15 539 -6.05% | 14 283 13 783 3.63% | 13 177 13 123 0.41% | 9 666 |
EBIT Million USD | Released Forecast Spread | 11 064 11 571 -4.38% | 11 704 11 599 0.9% | 12 548 13 943 -10.01% | 12 180 12 141 0.32% | 10 484 10 687 -1.9% | 7 243 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 5 160 5 333 -3.24% | 1 669 1 636 2.01% | 8 278 9 507 -12.92% | 5 814 5 658 2.76% | 6 859 7 323 -6.33% | 1 509 |
Net income Million USD | Released Forecast Spread | 5 386 4 292 25.5% | 123 137 -10.03% | 6 225 7 205 -13.6% | 4 592 4 383 4.77% | 5 665 5 872 -3.52% | 403 |
EPS USD | Released Forecast Spread | 4,22 3,43 23.14% | 0,10 0,12 -16.23% | 4,93 5,75 -14.19% | 3,64 3,48 4.75% | 4,50 4,69 -3.96% | 0,34 |
Announcement Date | 04/02/20 | 04/02/21 | 01/02/22 | 02/02/23 | 06/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 6 590 6 279 4.96% | 6 260 5 873 6.6% | 7 042 6 133 14.82% | 7 389 6 630 11.45% | 6 352 6 326 0.41% | 6 599 6 454 2.24% | 7 051 6 800 3.69% | 7 115 7 104 0.16% | 6 686 6 349 5.31% | 6 703 | 6 972 | 7 231 | 6 484 | 6 781 |
EBITDA Million USD | Released Forecast Spread | 4 049 3 438 17.79% | 3 195 3 183 0.38% | 3 811 3 049 24.99% | 3 227 2 865 12.63% | 2 883 3 407 -15.38% | 3 258 3 343 -2.54% | 3 908 3 636 7.49% | 3 427 3 495 -1.94% | -889 | 3 365 | 3 541 | 3 543 | ||
EBIT Million USD | Released Forecast Spread | 3 524 3 060 15.15% | 2 670 2 602 2.6% | 3 286 2 529 29.91% | 2 699 2 622 2.92% | 2 243 2 658 -15.62% | 2 277 2 776 -17.99% | 3 224 3 060 5.37% | 2 739 2 940 -6.84% | -1 117 -1 679 33.48% | 2 675 | 2 897 | 2 918 | 2 605 | 2 729 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -152 2 158 -107.05% | 1 503 1 664 -9.68% | 2 432 1 674 45.28% | 2 031 1 840 10.37% | 1 300 1 900 -31.59% | 1 588 1 969 -19.35% | 2 318 2 275 1.91% | 1 653 2 090 -20.89% | -4 486 | 1 789 | 2 106 | 2 207 | 2 197 | 2 270 |
Net income Million USD | Released Forecast Spread | 19,0 1 611 -98.82% | 1 144 1 367 -16.32% | 1 789 1 248 43.39% | 1 640 1 438 14.02% | 1 010 1 587 -36.37% | 1 045 1 545 -32.38% | 2 180 1 801 21.07% | 1 429 1 599 -10.66% | -4 170 -2 888 -44.38% | 1 379 | 1 599 | 1 647 | 1 651 | 1 732 |
EPS USD | Released Forecast Spread | 0,02 1,34 -98.5% | 0,91 1,11 -17.89% | 1,42 1,01 40.93% | 1,30 1,15 13% | 0,80 1,23 -34.75% | 0,83 1,20 -30.93% | 1,73 1,43 20.88% | 1,14 1,28 -11.05% | -3,34 -1,92 -74.06% | 1,11 | 1,28 | 1,31 | 1,24 | 1,32 |
Announcement Date | 28/04/22 | 02/08/22 | 27/10/22 | 02/02/23 | 27/04/23 | 03/08/23 | 07/11/23 | 06/02/24 | 25/04/24 | - | - | - | - | - |
Past sector events for Gilead Sciences, Inc.
2024-05-30 08:08 am | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
2024-05-30 07:00 am | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
2024-05-30 02:24 am | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
2024-05-29 08:00 am | FDC LIMITED: Q4 2024 Earnings Release |
2024-05-29 05:26 am | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
2024-05-29 04:44 am | ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release |
2024-05-29 04:10 am | IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release |
2024-05-28 | PFIZER LIMITED: Q4 2024 Earnings Release |
2024-05-27 | DOTTIKON ES HOLDING AG: Q4 2024 Earnings Release |
2024-05-27 08:10 am | ASTRAZENECA PHARMA INDIA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GILD Stock
- Calendar Gilead Sciences, Inc.